Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Mankind Pharma Ltd.

BSE: 543904 | NSE: MANKIND |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE634S01028 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Dec 24, 13:58
2203.85 -26.50 (-1.19%)
Volume
AVERAGE VOLUME
5-Day
23,200
10-Day
23,982
30-Day
25,051
9,002
  • Prev. Close

    2230.35

  • Open Price

    2231.75

  • Bid Price (Qty.)

    2202.00 (5)

  • Offer Price (Qty.)

    2203.80 (6)

NSE Live

Dec 24, 13:58
2202.90 -26.70 (-1.20%)
Volume
AVERAGE VOLUME
5-Day
462,327
10-Day
559,087
30-Day
795,408
164,874
  • Prev. Close

    2229.60

  • Open Price

    2239.90

  • Bid Price (Qty.)

    2202.80 (19)

  • Offer Price (Qty.)

    2202.90 (1)

Financials

Cash Flow of Mankind Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 2,390.36 2,259.57 1,562.84 1,797.54 1,440.21  
Net CashFlow From Operating Activities 2,322.16 1,982.97 1,798.99 812.29 1,022.33  
Net Cash Used In Investing Activities -12,114.68 -1,919.12 -1,040.61 -1,369.34 -1,127.16  
Net Cash Used From Financing Activities 9,845.34 -8.68 -710.41 578.92 88.87  
Foreign Exchange Gains / Losses -2.28 -0.10 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others -61.87 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -11.33 55.07 47.96 21.87 -15.96  
Cash And Cash Equivalents Begin of Year 211.62 134.13 86.17 22.58 77.50  
Cash And Cash Equivalents End Of Year 200.29 189.20 134.13 44.45 61.53  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347